Hermon Arnica Cream Sensitive Skin Formula 2 Oz

Topical Application

For bruising or muscle pain, apply a thin layer of Arnica gel or cream to the affected area 3 to 4 times daily. Ensure the area is clean and free of open wounds.

Oral Homeopathic Dosing

Typical homeopathic dosing involves dissolving 3 to 5 pellets under the tongue three times daily. Note that homeopathic preparations are distinct from herbal tinctures and are generally considered safe due to extreme dilution.

Arnica Montana should be used with caution in children. While topical homeopathic gels are often used for minor bumps in children over 2 years of age, you must consult a pediatrician before use. Pure Arnica extract is not approved for pediatric oral consumption due to toxicity risks.

Renal and Hepatic Impairment

No specific dosage adjustments are provided for topical use. However, patients with severe liver or kidney disease should avoid oral ingestion of non-homeopathic Arnica due to potential systemic toxicity.

Elderly Patients

Elderly patients may have thinner skin, which can increase the absorption of topical preparations. Monitor for localized skin irritation.

• Topical: Do not apply to broken skin, mucous membranes, or near the eyes.
• Oral: Take homeopathic pellets at least 15 minutes before or after eating or drinking.
• Storage: Store at room temperature (20°C to 25°C) away from direct sunlight and moisture.

If you miss a dose, apply or take it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose.

Signs of oral overdose (ingestion of the plant or concentrated tincture) include severe gastroenteritis (stomach upset), tachycardia (fast heart rate), muscle weakness, and shortness of breath. In case of accidental ingestion, contact a Poison Control Center or seek emergency medical attention immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

• Contact Dermatitis: Redness, itching, or a small rash at the site of topical application.
• Dry Skin: Flaking or peeling where the gel is applied.

• Vesicular Dermatitis: Formation of small blisters on the skin.
• Increased Sensitivity: The skin may become more sensitive to sunlight in the treated area.

• Severe Allergic Reaction: Hives or generalized itching.
• Gastrointestinal Distress: Mild nausea if homeopathic pellets are taken on an empty stomach.

> Warning: Stop taking Arnica Montana and call your doctor immediately if you experience any of these:

• Anaphylaxis: Difficulty breathing, swelling of the face, lips, or tongue, and severe dizziness.
• Cardiac Arrhythmia: Irregular heartbeat or palpitations (associated with systemic absorption).
• Severe Skin Sloughing: Extensive blistering or peeling of the skin.

Prolonged topical use on the same area may lead to chronic skin irritation or the development of a permanent allergy to the Asteraceae (Compositae) plant family.

No FDA black box warnings currently exist for Arnica Montana when used in homeopathic or topical forms. However, the FDA has issued warnings regarding the oral ingestion of undiluted Arnica Montana due to its classification as an unsafe herb by the agency when not in homeopathic dilution.

Report any unusual symptoms to your healthcare provider.

Arnica Montana is for external use only (unless in homeopathic pellet form). It should never be applied to open wounds or broken skin, as systemic absorption can occur, leading to toxicity.

No FDA black box warnings for Arnica Montana.

• Allergic Reactions: Patients with known allergies to the Asteraceae family (including ragweed, marigolds, daisies, and chrysanthemums) are at a high risk of cross-sensitivity and should avoid Arnica.
• Hepatotoxicity: While rare with topical use, the helenalin in Arnica can be toxic to liver cells if ingested in significant quantities.
• Bleeding Risk: Arnica contains natural coumarins. While systemic levels from topical use are low, it should be used cautiously in patients with bleeding disorders.

No routine lab tests are required for short-term topical use. For patients using Arnica extensively post-surgery, providers may monitor:

• Liver Function Tests (LFTs) if systemic toxicity is suspected.
• Coagulation Profiles (PT/INR) if used alongside blood thinners.

Arnica Montana typically does not interfere with the ability to drive or operate machinery.

There are no known direct interactions between alcohol and topical Arnica; however, alcohol can increase bruising and swelling, potentially counteracting the benefits of the medication.

Arnica can be stopped abruptly without tapering. If a rash develops, discontinue use immediately.

> Important: Discuss all your medical conditions with your healthcare provider before starting Arnica Montana.

• Undiluted Arnica + Oral Consumption: Pure Arnica extract must never be ingested. This can lead to fatal poisoning characterized by cardiovascular collapse.

• Anticoagulants (e.g., Warfarin, Heparin): Arnica may theoretically increase the risk of bleeding. Although systemic absorption from topical use is low, patients on therapeutic anticoagulation should be monitored closely.
• Antiplatelet Drugs (e.g., Clopidogrel, Aspirin): Combined use may increase the risk of bruising or bleeding.

• Antihypertensives: Because Arnica may act as an alpha/beta-adrenergic agonist, it could potentially interfere with the efficacy of blood pressure medications.
• NSAIDs (e.g., Ibuprofen, Naproxen): Concurrent use may increase the risk of gastrointestinal irritation if Arnica is absorbed systemically.

• Herbal Teas: Avoid consuming teas containing other coumarin-rich herbs (like sweet clover) while using Arnica.

• Ginkgo Biloba / Garlic / Ginger: These supplements have blood-thinning properties and may increase the risk of bleeding when used with Arnica.
• St. John's Wort: May increase skin sensitivity to light when combined with topical Arnica.

Arnica Montana may interfere with blood glucose monitoring or coagulation tests (PT/INR) if significant systemic absorption occurs, though this is clinically rare for topical applications.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Hypersensitivity: Known allergy to Arnica Montana or any member of the Asteraceae/Compositae family.
• Broken Skin: Application to open wounds, ulcers, or abraded skin is strictly contraindicated due to the risk of systemic toxicity.
• Internal Use: Ingestion of non-homeopathic Arnica preparations.

• Peptic Ulcer Disease: Use with caution, as systemic absorption may exacerbate GI irritation.
• Pregnancy and Lactation: Due to a lack of safety data regarding systemic absorption, use is generally discouraged unless directed by a physician.

Patients allergic to the following plants may experience cross-reactions:

• Ragweed
• Chrysanthemums
• Marigolds
• Daisies

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Arnica Montana.

FDA Category: Not Formally Assigned. Arnica Montana is traditionally considered an emmenagogue (a substance that stimulates menstrual flow) and may have uterine-stimulating effects. Oral ingestion is contraindicated during pregnancy. Topical use should be limited and supervised by a healthcare provider.

It is unknown if Arnica constituents pass into breast milk. To prevent accidental ingestion by the infant, do not apply Arnica to the breast or nipple area while nursing.

Safe use in children under 2 years of age has not been established. Homeopathic preparations are generally considered safe for older children when used according to label instructions.

Elderly patients may be more susceptible to skin irritation. Clinical studies have not identified specific age-related differences in response, but caution is advised due to potential polypharmacy (multiple medications) and increased bleeding risk.

No specific dosage adjustments are required for topical use. Avoid systemic exposure in patients with GFR < 30 mL/min.

Use with caution in patients with Child-Pugh Class B or C due to the potential for sesquiterpene lactones to cause hepatotoxic stress if absorbed.

> Important: Special populations require individualized medical assessment.

Arnica Montana acts primarily by inhibiting the NF-κB signaling pathway. Specifically, helenalin binds to the p65 subunit of NF-κB, preventing it from binding to DNA and initiating the inflammatory cascade. It also acts as an Adrenergic alpha and beta agonist, which may modulate local vasoconstriction and vasodilation to assist in the removal of metabolic waste from injured tissues.

• Onset of Action: Topical relief may be felt within 15–30 minutes.
• Duration: Effects typically last 4–6 hours.
• Tolerance: No known tolerance development with short-term use.

| Parameter | Value |

|---|---|

| Bioavailability | High (Topical/Local); Low (Systemic/Homeopathic) |

| Protein Binding | Unknown |

| Half-life | 2–4 hours (estimated for helenalin) |

| Tmax | 1–2 hours (Topical absorption) |

| Metabolism | Hepatic (Oxidation) |

| Excretion | Renal (Primary) |

• Molecular Formula: C15H18O4 (Helenalin)
• Molecular Weight: 262.3 g/mol
• Solubility: Soluble in ethanol and organic solvents; poorly soluble in water.

Arnica Montana is a Non-Standardized Plant Allergenic Extract [EPC]. It shares therapeutic space with topical NSAIDs (like Diclofenac) and other botanical counter-irritants.